An experimental drug was produced clinically meaningful pain relief among surgical and non-surgical pain conditions, and the therapy could fill the gap between safe, low-efficacy medicines and opioid treatments, its manufacturer said Jan. 30.
As the effects of the COVID-19 pandemic have lessened, officials at Ann Arbor-based Michigan Medicine, which includes University of Michigan Health and the university's medical school, have been able to invest in innovative care, including expanding its specialty and mail-order…
After the FDA approved the first over-the-counter emergency contraception in 2006, emergency department visits for the medication decreased by 96% over the next 14 years, according to a new study.
Levemir, one of the three types of long-acting basal insulins, is evacuating the U.S. market, and diabetes patient advocates told USA Today they're worried about using a new medication after nearly two decades.
The FDA has given the green light to Sanofi's drug Dupixent to be used as treatment in pediatric patients with chronic eosinophilic esophagitis, the pharmaceutical company announced Jan. 25.
Baptist Health's central pharmacy center is months away from filling up to 14,000 prescriptions a day, and the facility will be the nation's most automated central pharmacy.
Walgreens has reached a $275,000 settlement with the state of Vermont over allegations that medication and vaccination errors and other alleged violations created unsafe conditions for patients and staff at the chain's pharmacies across the state.